Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Earnings Per Share - Reconciliation of Basic and Diluted EPS and Shares (Details)

v3.23.3
Note 5 - Earnings Per Share - Reconciliation of Basic and Diluted EPS and Shares (Details) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Income (loss) from continuing operations $ 6,141     $ 6,894     $ 16,378 $ 34,194
Income from continuing operations attributable to unvested shares (58)     (75)     (73) (457)
Numerator for basic (6,083)     (6,819)     (16,305) (33,737)
Loss from continuing operations attributable to unvested shares (8)     0     (49) 3
Numerator for dilutive 6,075     6,819     16,256 33,740
Loss from discontinued operations, net of tax 0     (26)     (15) (58)
Loss from discontinued operations attributable to unvested shares 0     0     0 1
Numerator for basic 0     (26)     (15) (57)
(Income) loss from discontinued operations attributable to unvested shares 0     0     0 0
Numerator for dilutive 0     (26)     (15) (57)
Net income (loss) 6,141 $ 6,752 $ 3,470 6,868 $ 15,104 $ 12,164 16,363 34,136
Net income attributable to unvested shares (66)     (75)     (122) (456)
Numerator for basic 6,075     6,793     16,241 33,680
Net (income) loss attributable to unvested shares (8)     0     (49) 3
Numerator for dilutive $ 6,067     $ 6,793     $ 16,192 $ 33,683
Basic weighted average shares outstanding (in shares) 106,289     59,068     106,876 58,900
Effect of dilutive securities (in shares) 144     382     196 435
Diluted weighted average shares outstanding (in shares) 106,433     59,450     107,072 59,335
Stock options and unvested restricted stock grants excluded from dilutive calculation because they would be anti-dilutive (in shares) 530     388     336 195